A protein called Menin quietly disappears from a deep brain region as mammals age, and research published in PLOS Biology suggests that disappearance triggers a cascade of systemic decline — inflammation, memory loss, weaker bones, and thinning skin. Restoring Menin in elderly mice reversed most of those changes within 30 days. A simpler intervention, supplementing with a common amino acid called D-serine, restored memory on its own in aged animals. The findings add molecular precision to a fast-growing hypothesis: that a pea-sized structure at the base of the brain is quietly setting the pace of aging for the entire body.
The study, led by Lige Leng and colleagues at Xiamen University in China, was published in March 2023 in PLOS Biology. It has attracted renewed attention in May 2026 as part of a broader surge of converging research placing the hypothalamus at the center of systemic aging biology — a wave that includes a parallel discovery at the University of California, San Francisco, published last August, identifying a separate protein called FTL1 as a driver of brain aging that is also reversible in mice.
Menin: What It Is, and What Happens When It Fades
Menin is best known to oncologists. Mutations in the gene that encodes it are linked to multiple endocrine neoplasia type 1, a hereditary condition that causes tumors in hormone-producing glands. Its role in the healthy aging brain had received almost no attention until Leng's group looked closely.
What they found was consistent and age-dependent: Menin levels in the ventromedial hypothalamus — a specific subregion governing metabolism, hormone balance, and energy homeostasis — fell sharply as mice grew older. The decline was selective, occurring in hypothalamic neurons but not in neighboring support cells called astrocytes or microglia.
To test whether that decline was a passive marker of aging or an active driver, the team engineered younger mice in which Menin activity could be switched off in those same neurons. The result was striking. Younger mice with artificially depleted Menin developed heightened brain inflammation, deteriorating memory performance, weaker bones, thinning skin, and measurably shorter lifespans — all before their natural age. The researchers also ran the experiment in reverse. When they injected the Menin gene directly into the hypothalamus of mice roughly 20 months old — late in the mouse lifespan, roughly equivalent to advanced age in humans — the animals showed measurable improvement in learning and memory tasks, improved balance, restored skin thickness, and increased bone density within 30 days.
"We speculate that the decline of Menin expression in the hypothalamus with age may be one of the driving factors of aging, and Menin may be the key protein connecting the genetic, inflammatory, and metabolic factors of aging," Leng said in a statement accompanying the research.
How Menin Loss Triggers Brain Inflammation
The mechanism centers on a signaling pathway already implicated in hypothalamic aging: the IKKβ/NF-κB inflammatory cascade. In healthy neurons, Menin binds to a molecule called p65 and suppresses NF-κB activity, holding inflammatory signaling in check. When Menin falls, that brake releases. Neuroinflammation rises in the ventromedial hypothalamus, and the downstream effects ripple outward through the nervous and endocrine systems the hypothalamus regulates.
The hypothalamus communicates bidirectionally with almost every major organ system. It sets circadian rhythms, regulates hunger and thirst, controls body temperature, governs stress hormones, and coordinates reproductive physiology. A growing body of work over the past decade has argued that hypothalamic inflammation does not merely accompany aging — it accelerates it. A landmark 2017 study by Dongsheng Cai's lab at Albert Einstein College of Medicine linked the loss of stem cells in the hypothalamus to shortened lifespan in mice, establishing that the region actively governs the body's aging clock rather than simply reflecting it. The Menin findings offer a more upstream molecular handle on the same axis.
D-Serine Supplement Cognitive Decline: What the Research Shows
Among the study's most practically significant findings was the discovery of how Menin loss depletes a neurotransmitter called D-serine. Menin appears to control the activity of an enzyme required for D-serine synthesis. When Menin falls, that enzyme becomes less active, D-serine production drops, and communication between neurons in the hippocampus — the brain region most directly responsible for memory formation — deteriorates.
This matters beyond the mechanism itself. D-serine is a dietary amino acid that also serves as a neurotransmitter, acting at NMDA receptors to support what researchers call synaptic plasticity — the process by which neural connections strengthen during learning. It occurs naturally in soybeans, eggs, fish, and nuts, and is sold as a dietary supplement. When the Xiamen team gave aged mice three weeks of D-serine supplementation directly, the animals performed significantly better on cognitive tests. The supplement did not, however, reverse the physical aging markers — the bone loss and skin thinning — that Menin restoration had addressed. That asymmetry suggests Menin regulates aging through multiple parallel pathways, of which D-serine depletion is one but not the only one.
What the Research Does Not Yet Show
Every finding in this study is from mice, and the gap between mouse models and human therapeutics is wide and well-documented. Dr. Santosh Kesari, director of neuro-oncology at the Pacific Neuroscience Institute, said the underlying biology is likely transferable — noting that hypothalamic-pituitary-adrenal axis markers offer accessible blood-based targets for studying this pathway in humans — but no clinical trials are planned or expected in the near term.
The path to any Menin-based therapy in humans faces a significant specific barrier: delivering a gene or protein intervention across the blood-brain barrier and into a precise hypothalamic subregion requires technology that does not yet exist at clinical scale. D-serine supplementation faces a different set of concerns. The compound activates NMDA receptors, which in excess can cause excitotoxic neuronal damage, and its long-term safety profile in older adults has not been established in large trials. The Alzheimer's Drug Discovery Foundation notes that the clinical evidence for D-serine's cognitive benefits in humans is mixed and inconsistent. Readers who encounter D-serine supplements marketed for memory should know that the dose, delivery, and safety profile studied in mice do not map directly to any commercially available product.
Hypothalamus Aging Research Gains Momentum in 2025-2026
The Menin findings are one node in a rapidly thickening network of research pointing to the hypothalamus as a master regulator of systemic aging. In August 2025, researchers at UCSF published a study in Nature Aging identifying ferritin light chain 1 as a pro-aging driver in hippocampal neurons — also reversible in mice when reduced — and described the result as a genuine reversal of impairments rather than a delay of symptoms. In March 2025, a separate group demonstrated that restoring neuropeptide Y levels in the hypothalamus ameliorated premature aging phenotypes in mice. A 2024 study in Nature Communications found that the hypothalamus undergoes distinctive epigenetic changes with age, potentially influencing pathways tied to oxytocin and gonadotropin-releasing hormone, both linked to cognitive aging.
Together, these findings represent a shift in how aging researchers frame the question. Rather than treating decline as the sum of independent failures across organs and tissues, a growing number of researchers are asking whether the brain is actively coordinating parts of the process — and whether interrupting that coordination can reset the clock.
Does This Mean Human Aging Can Be Reversed?
For most readers, the answer for now is: not yet, and the path is long. Menin does not exist in a supplementable form, and the gene therapy approach used in mice would require years of safety and delivery research before any human application. D-serine is accessible, but the evidence for cognitive benefit in aging humans remains preliminary and the safety questions around chronic high-dose use have not been resolved.
What the study does establish — with unusual specificity — is a causal chain: one protein, declining in one brain region, appears sufficient to trigger a recognizable constellation of aging changes across the body. That is a target precise enough for pharmaceutical development, and it opens the hypothalamus to a new class of intervention strategies that did not exist before this work.
"D-serine is a potentially promising therapeutic for cognitive decline," Leng said. The caveat embedded in the word "promising" reflects where the science currently stands.
Frequently Asked Questions
Can brain aging be reversed in humans?
No human trials have demonstrated that the Menin-based approach works in people. The findings — including partial reversal of memory loss and physical aging markers — are from mouse models at Xiamen University. Translating these results to humans requires clinical research that has not yet begun, including solutions to the significant challenge of delivering precise gene or protein interventions to a specific hypothalamic subregion in the human brain.
What is D-serine and does it help with memory?
D-serine is an amino acid that functions as a neurotransmitter in the brain, activating NMDA receptors involved in learning and memory. It occurs naturally in soybeans, eggs, fish, and nuts and is also sold as a supplement. In aged mice, three weeks of D-serine supplementation improved cognitive performance. In human studies, results have been mixed, and the Alzheimer's Drug Discovery Foundation notes that clinical evidence for cognitive benefits is inconsistent. Long-term safety in older adults has not been established.
How does the hypothalamus control aging?
The hypothalamus is a small brain region that regulates metabolism, hormones, body temperature, and stress responses. Research over the past decade — including a landmark 2017 study linking hypothalamic stem cell loss to shortened lifespan — has identified it as a likely central regulator of systemic aging, not merely a passive bystander. The Menin findings add a specific molecular mechanism: declining Menin in hypothalamic neurons releases inflammatory signaling that accelerates aging changes across multiple organ systems.
What is the Menin protein aging connection?
Menin is a protein produced in hypothalamic neurons that suppresses neuroinflammation by inhibiting the NF-κB signaling pathway. As mice age, Menin levels in the ventromedial hypothalamus fall. The Xiamen University research showed that this decline appears to cause — not merely accompany — accelerated aging. Mice engineered to lack Menin in those neurons aged prematurely; mice in which Menin was restored showed reversal of multiple aging markers within 30 days.
ⓒ 2026 TECHTIMES.com All rights reserved. Do not reproduce without permission.
